Thomas F. Kearns's most recent trade in FibroGen Inc was a trade of 13,100 Common Stock done at an average price of $11.6 . Disclosure was reported to the exchange on Sept. 15, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FibroGen Inc | Thomas F. Kearns | Director | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 15 Sep 2021 | 13,100 | 39,764 (0%) | 0% | 11.6 | 151,707 | Common Stock |
| FibroGen Inc | Thomas F. Kearns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Thomas F. Kearns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 52,864 (0%) | 0% | 0 | Common Stock | |
| FibroGen Inc | Thomas F. Kearns | Director | Sale of securities on an exchange or to another person at price $ 35.02 per share. | 11 Mar 2021 | 18,000 | 148,164 (0%) | 0% | 35.0 | 630,360 | Common Stock |
| FibroGen Inc | Thomas F. Kearns | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.50 per share. | 11 Mar 2021 | 18,000 | 166,164 (0%) | 0% | 3.5 | 63,000 | Common Stock |
| FibroGen Inc | Thomas F. Kearns | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 12,000 | 0 | - | - | Stock Option (Right to Buy) | |
| FibroGen Inc | Thomas F. Kearns | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 6,000 | 0 | - | - | Stock Option (Right to Buy) |